Lv41
750 积分 2021-09-22 加入
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program
2个月前
已完结
Significant reduction in chronic kidney disease progression with sodium‐glucose cotransporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease
4个月前
已完结
High-intensity interval training, caloric restriction, or their combination have beneficial effects on metabolically acquired peripheral neuropathy
7个月前
已完结
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
9个月前
已完结
New perspectives in diabetic neuropathy
9个月前
已完结
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
10个月前
已完结
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
1年前
已完结
Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations
1年前
已完结
An obesogenic diet impairs uncoupled substrate oxidation and promotes whitening of the brown adipose tissue in rats
2年前
已完结
Systematic review with meta‐analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations
3年前
已完结
皖公网安备34019202002308
